Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xi Tian, Denise Haunani Solomon & Rachel A. Smith. (2020) A Stress Buffering Perspective on the Progression of Alpha-1 Antitrypsin Deficiency. Health Communication 35:6, pages 747-755.
Read now
Read now
Tatsiana Beiko & Charlie Strange. (2019) Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life. Therapeutics and Clinical Risk Management 15, pages 959-964.
Read now
Read now
Jorge E. Lascano & Michael A. Campos. (2017) The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency. Postgraduate Medicine 129:8, pages 889-895.
Read now
Read now
Antonio Anzueto. (2015) Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:4, pages 462-467.
Read now
Read now
Sandra Manca, Esther Rodriguez, Arturo Huerta, Maria Torres, Lourdes Lazaro, Sergio Curi, Pietro Pirina & Marc Miravitlles. (2014) Usefulness of the CAT, LCOPD, EQ-5D and COPDSS Scales in Understanding the Impact of Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:5, pages 480-488.
Read now
Read now
Articles from other publishers (8)
Lauren H. Fairley, Shatarupa Das, Vivek Dharwal, Nadia Amorim, Karl J. Hegarty, Ridhima Wadhwa, Guntipally Mounika & Philip M. Hansbro. (2023) Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease. Antioxidants 12:4, pages 973.
Crossref
Crossref
Marc Miravitlles, Mike Herepath, Asim Priyendu, Sheetal Sharma, Tatiana Vilchez, Oliver Vit, Michaela Haensel, Virginie Lepage, Helena Gens & Timm Greulich. (2022) Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews. European Respiratory Review 31:163, pages 210262.
Crossref
Crossref
Mark P. Murphy, Thomas McEnery, Karen McQuillan, Oisín F. McElvaney, Oliver J. McElvaney, Sarah Landers, Orla Coleman, Anchalin Bussayajirapong, Padraig Hawkins, Michael Henry, Paula Meleady, Emer P. Reeves & Noel G. McElvaney. (2020)
α
1
Antitrypsin therapy modulates the neutrophil membrane proteome and secretome
. European Respiratory Journal 55:4, pages 1901678.
Crossref
Crossref
A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira & L. Telo. (2018) Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 24, pages 1-21.
Crossref
Crossref
Kristen E. Holm, David M. Mannino, Radmila Choate & Robert A. Sandhaus. (2018) Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease. Respiratory Medicine 143, pages 48-55.
Crossref
Crossref
Christopher M. Blanchette, Emily Zacherle, Joshua M. Noone, Bryce A. Van Doren, Debosree Roy & Reuben Howden. (2017) One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States. Journal of Health Economics and Outcomes Research 5:1, pages 65-74.
Crossref
Crossref
Catherine M. Greene, Stefan J. Marciniak, Jeffrey Teckman, Ilaria Ferrarotti, Mark L. Brantly, David A. Lomas, James K. Stoller & Noel G. McElvaney. (2016) α1-Antitrypsin deficiency. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
A. Cuvelier & J.-F. Mornex. (2014) Le déficit en alpha-1 antitrypsine : avancées des connaissances et questions restantes. Revue des Maladies Respiratoires 31:4, pages 295-299.
Crossref
Crossref